title: Immune checkpoint inhibitors-related orchitis.
authors.affiliation: Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie, rue Henri Huchard, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Brunet-Possenti
authors.affiliation: Department of Pharmacy, University Hospital, rue Gaffarel, Dijon, France.
authors.forename: M A
authors.initials: MA
authors.lastname: Opsomer
authors.affiliation: INSERM E 0226, Université Claude Bernard Lyon I, Lyon, France.
authors.forename: L
authors.initials: L
authors.lastname: Gomez
authors.affiliation: Urology, Bichat Claude Bernard Hospital, AP-HP, Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: Ouzaid
authors.affiliation: Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie, rue Henri Huchard, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Descamps
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D000074324:Ipilimumab / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology; D008875:Middle Aged; D000077594:Nivolumab; D009920:Orchitis / Q000139:chemically induced* / Q000276:immunology; D000072078:Positron Emission Tomography Computed Tomography
chemical_list: D000911:Antibodies, Monoclonal; D000074322:Antineoplastic Agents, Immunological; D000074324:Ipilimumab; D000077594:Nivolumab